ALLAKOS INC's ticker is ALLK and the CUSIP is 01671P100. A total of 127 filers reported holding ALLAKOS INC in Q2 2020. The put-call ratio across all filers is 0.79 and the average weighting 0.2%.
Links
Filings
- All filings
- Annual reports (10-K)
- Quarterly reports (10-Q)
- Insider transactions
- Shareholder votes
- Significant ownership
- Events
EDGAR links
External links
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2023 | $6,795,439 | -48.8% | 1,527,065 | -3.0% | 0.02% | -54.1% |
| Q4 2022 | $13,261,121 | +23.0% | 1,574,955 | -10.6% | 0.04% | +15.6% |
| Q3 2022 | $10,779,000 | +95.4% | 1,761,284 | -0.0% | 0.03% | +113.3% |
| Q2 2022 | $5,515,000 | +630.5% | 1,761,867 | +1229.5% | 0.02% | +650.0% |
| Q1 2022 | $755,000 | +25066.7% | 132,523 | +389673.5% | 0.00% | – |
| Q2 2021 | $3,000 | -99.6% | 34 | -99.4% | 0.00% | -100.0% |
| Q1 2021 | $701,000 | -67.3% | 6,103 | -60.1% | 0.00% | -75.0% |
| Q4 2020 | $2,144,000 | +107100.0% | 15,313 | +29348.1% | 0.00% | – |
| Q1 2020 | $2,000 | -99.8% | 52 | -99.5% | 0.00% | -100.0% |
| Q3 2019 | $819,000 | – | 10,421 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Samsara BioCapital, LLC | 270,965 | $12,055,000 | 6.94% |
| NEA Management Company, LLC | 2,268,188 | $100,912,000 | 5.27% |
| Fairmount Funds Management LLC | 178,662 | $7,949,000 | 4.82% |
| Redmile Group, LLC | 2,976,928 | $132,444,000 | 3.71% |
| Boxer Capital, LLC | 675,000 | $30,031,000 | 2.05% |
| Rock Springs Capital Management LP | 235,000 | $10,455,000 | 0.43% |
| Cormorant Asset Management, LP | 200,000 | $8,898,000 | 0.41% |
| RAMIUS ADVISORS LLC | 31,155 | $1,386,000 | 0.35% |
| INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 15,700 | $692,000 | 0.32% |
| Handelsinvest Investeringsforvaltning | 20,000 | $890,000 | 0.24% |